Drug Trial Radar · NCT06400004
Lumason® Infusion vs. Bolus Administrations
Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
106
Planned (sponsor's estimate)
Start
Jul 10, 2024
Primary completion
Aug 29, 2026
Study completion Dec 31, 2026
Sponsor
- Lead sponsor
- Bracco Diagnostics, IncIndustry
- Sponsor type
- Industry
- First posted
- May 6, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Single (outcomes assessor)
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A phase III study designed as a randomized, within-patient comparison of continuous infusion of diluted Lumason® versus the bolus administration of undiluted Lumason® for degree of LVO and assessment of LV EBD (co-primary endpoints).
Conditions
- Heart Diseases
Interventions
Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]Drug
Bolus administration of 2 mL undiluted Lumason®, to be administered in 20 seconds
LumasonDrug
Continuous infusion of 8 mL of diluted Lumason® (4 mL of Lumason® diluted in 4 mL of saline) at a rate of 1.0 mL/min
Primary outcomes
What the sponsor says the trial is designed to measure.
- Adequate LV EBD ScoreTime frame: 2-3 Hours
- Adequate LV OpacificationTime frame: 2-3 Hours
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Interventional Cardiology Medical Group
West Hills, California · Recruiting
Piedmont Heart Institute
Atlanta, Georgia · Recruiting
Beth Israel Deaconess Medical Center
Boston, Massachusetts · Recruiting
Oregon Health and Sciences University
Portland, Oregon · Not yet recruiting
University of Texas Medical Branch
Galveston, Texas · Withdrawn
Vital Heart and Vein
Humble, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.